in the present study this capacity was assessed in the plasma of patients suffering from cervical carcinoma ( ce . ca . ) and of patients suffering from cervical dysplasia ( ce . dis . ) regarded as being at high risk to develop cancer .
C0302592
cervical carcinoma
C0006826
cancer